Location · Henderson, NV
Clinical trials in Henderson, NV
16 recruiting studies have a site in Henderson, and 1 of them accept healthy volunteers.
16 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2/Phase 3
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Pfizer
- Location
- Henderson, NV + 58 other US sites
- Eligibility basics
- Ages 35–80
- RecruitingPhase 3
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
AstraZeneca
- Location
- Henderson, NV + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- Henderson, NV + 72 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Akero Therapeutics, Inc
- Location
- Henderson, NV + 130 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Pfizer
- Location
- Henderson, NV + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
AstraZeneca
- Location
- Henderson, NV + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
GlaxoSmithKline
- Location
- Henderson, NV + 36 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
GlaxoSmithKline
- Location
- Henderson, NV + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
GlaxoSmithKline
- Location
- Henderson, NV + 29 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
GlaxoSmithKline
- Location
- Henderson, NV + 37 other US sites
- Eligibility basics
- Ages 40–75
- RecruitingPhase 3
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Axsome Therapeutics, Inc.
- Location
- Henderson, NV + 37 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited
- Location
- Henderson, NV + 26 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited
- Location
- Henderson, NV + 18 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Henderson, NV + 57 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
DiaSorin Molecular LLC
- Location
- Henderson, NV + 2 other US sites
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteers
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
Pacific Research Institute
- Location
- Henderson, NV + 8 other US sites
- Eligibility basics
- Ages 18+